Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Epidemiologic Trends in Malaria Incidence Among Travelers Returning to Metropolitan France, 1996-2016.

Kendjo E, Houzé S, Mouri O, Taieb A, Gay F, Jauréguiberry S, Tantaoui I, Ndour PA, Buffet P, Piarroux M, Thellier M, Piarroux R; French Imported Malaria Study Group.

JAMA Netw Open. 2019 Apr 5;2(4):e191691. doi: 10.1001/jamanetworkopen.2019.1691.

2.

Plasmodium falciparum Clearance Is Pitting-Dependent With Artemisinin-Based Drugs but Pitting-Independent With Atovaquone-Proguanil or Mefloquine.

Wojnarski M, Mouri O, Chambrion C, Roussel C, Chartrel N, Smith B, Smith P, Thellier M, Buffet P, Ndour PA.

J Infect Dis. 2019 Jul 2;220(3):535-539. doi: 10.1093/infdis/jiz115.

PMID:
30877300
3.

High-throughput microsphiltration to assess red blood cell deformability and screen for malaria transmission-blocking drugs.

Duez J, Carucci M, Garcia-Barbazan I, Corral M, Perez O, Presa JL, Henry B, Roussel C, Ndour PA, Rosa NB, Sanz L, Gamo FJ, Buffet P.

Nat Protoc. 2018 Jun;13(6):1362-1376. doi: 10.1038/nprot.2018.035. Epub 2018 May 24.

PMID:
29844524
4.

Measuring the Plasmodium falciparum HRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysis.

Ndour PA, Larréché S, Mouri O, Argy N, Gay F, Roussel C, Jauréguiberry S, Perillaud C, Langui D, Biligui S, Chartrel N, Mérens A, Kendjo E, Ghose A, Hassan MMU, Hossain MA, Kingston HWF, Plewes K, Dondorp AM, Danis M, Houzé S, Bonnefoy S, Thellier M, Woodrow CJ, Buffet PA; French Artesunate Working Group.

Sci Transl Med. 2017 Jul 5;9(397). pii: eaaf9377. doi: 10.1126/scitranslmed.aaf9377.

PMID:
28679662
5.

Artesunate to treat severe malaria in travellers: review of efficacy and safety and practical implications.

Roussel C, Caumes E, Thellier M, Ndour PA, Buffet PA, Jauréguiberry S.

J Travel Med. 2017 Mar 1;24(2). doi: 10.1093/jtm/taw093. Review.

PMID:
28395097
6.

Spherocytic shift of red blood cells during storage provides a quantitative whole cell-based marker of the storage lesion.

Roussel C, Dussiot M, Marin M, Morel A, Ndour PA, Duez J, Le Van Kim C, Hermine O, Colin Y, Buffet PA, Amireault P.

Transfusion. 2017 Apr;57(4):1007-1018. doi: 10.1111/trf.14015. Epub 2017 Feb 1.

PMID:
28150311
7.

Stage-dependent fate of Plasmodium falciparum-infected red blood cells in the spleen and sickle-cell trait-related protection against malaria.

Diakité SA, Ndour PA, Brousse V, Gay F, Roussel C, Biligui S, Dussiot M, Prendki V, Lopera-Mesa TM, Traoré K, Konaté D, Doumbia S, Cros J, Dokmak S, Fairhurst RM, Diakité M, Buffet PA.

Malar J. 2016 Sep 21;15(1):482.

8.

Anti-Self Phosphatidylserine Antibodies Recognize Uninfected Erythrocytes Promoting Malarial Anemia.

Fernandez-Arias C, Rivera-Correa J, Gallego-Delgado J, Rudlaff R, Fernandez C, Roussel C, Götz A, Gonzalez S, Mohanty A, Mohanty S, Wassmer S, Buffet P, Ndour PA, Rodriguez A.

Cell Host Microbe. 2016 Feb 10;19(2):194-203. doi: 10.1016/j.chom.2016.01.009.

9.

Mechanical clearance of red blood cells by the human spleen: Potential therapeutic applications of a biomimetic RBC filtration method.

Duez J, Holleran JP, Ndour PA, Pionneau C, Diakité S, Roussel C, Dussiot M, Amireault P, Avery VM, Buffet PA.

Transfus Clin Biol. 2015 Aug;22(3):151-7. doi: 10.1016/j.tracli.2015.05.004. Epub 2015 Jun 29. Review.

PMID:
26138907
10.

Splenic retention of Plasmodium falciparum gametocytes to block the transmission of malaria.

Duez J, Holleran JP, Ndour PA, Loganathan S, Amireault P, Français O, El Nemer W, Le Pioufle B, Amado IF, Garcia S, Chartrel N, Le Van Kim C, Lavazec C, Avery VM, Buffet PA.

Antimicrob Agents Chemother. 2015 Jul;59(7):4206-14. doi: 10.1128/AAC.05030-14. Epub 2015 May 4.

11.

Delayed-onset hemolytic anemia in patients with travel-associated severe malaria treated with artesunate, France, 2011-2013.

Jauréguiberry S, Thellier M, Ndour PA, Ader F, Roussel C, Sonneville R, Mayaux J, Matheron S, Angoulvant A, Wyplosz B, Rapp C, Pistone T, Lebrun-Vignes B, Kendjo E, Danis M, Houzé S, Bricaire F, Mazier D, Buffet P, Caumes E; French Artesunate Working Group.

Emerg Infect Dis. 2015 May;21(5):804-12. doi: 10.3201/eid2105.141171.

12.

A biomimetic microfluidic chip to study the circulation and mechanical retention of red blood cells in the spleen.

Picot J, Ndour PA, Lefevre SD, El Nemer W, Tawfik H, Galimand J, Da Costa L, Ribeil JA, de Montalembert M, Brousse V, Le Pioufle B, Buffet P, Le Van Kim C, Français O.

Am J Hematol. 2015 Apr;90(4):339-45. doi: 10.1002/ajh.23941. Epub 2015 Feb 2.

13.

Patterns of anemia during malaria.

Jauréguiberry S, Ndour PA, Thellier M, Caumes E, Buffet P.

Int J Infect Dis. 2015 Apr;33:89. doi: 10.1016/j.ijid.2014.12.048. Epub 2015 Jan 7. No abstract available.

14.

Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria.

Ndour PA, Lopera-Mesa TM, Diakité SA, Chiang S, Mouri O, Roussel C, Jauréguiberry S, Biligui S, Kendjo E, Claessens A, Ciceron L, Mazier D, Thellier M, Diakité M, Fairhurst RM, Buffet PA.

J Infect Dis. 2015 Jan 15;211(2):290-7. doi: 10.1093/infdis/jiu427. Epub 2014 Sep 2.

15.

Postartesunate delayed hemolysis is a predictable event related to the lifesaving effect of artemisinins.

Jauréguiberry S, Ndour PA, Roussel C, Ader F, Safeukui I, Nguyen M, Biligui S, Ciceron L, Mouri O, Kendjo E, Bricaire F, Vray M, Angoulvant A, Mayaux J, Haldar K, Mazier D, Danis M, Caumes E, Thellier M, Buffet P; French Artesunate Working Group.

Blood. 2014 Jul 10;124(2):167-75. doi: 10.1182/blood-2014-02-555953. Epub 2014 May 23.

16.

LMP1-induced cell death may contribute to the emergency of its oncogenic property.

Brocqueville G, Ndour PA, Ouk TS, Le Goff A, De Witte C, Mougel A, Coll J, Fafeur V, Le Bourhis X, Adriaenssens E.

PLoS One. 2013 Apr 23;8(4):e60743. doi: 10.1371/journal.pone.0060743. Print 2013.

17.

Reduced deformability of circulating erythrocytes: a marker of hyposplenism.

Prendki V, Ndour PA, Jais X, Ciceron L, Settegrana C, Buffet P.

Am J Hematol. 2012 Oct;87(10):E81-2. doi: 10.1002/ajh.23297. Epub 2012 Jul 27. No abstract available.

18.

A switch in infected erythrocyte deformability at the maturation and blood circulation of Plasmodium falciparum transmission stages.

Tibúrcio M, Niang M, Deplaine G, Perrot S, Bischoff E, Ndour PA, Silvestrini F, Khattab A, Milon G, David PH, Hardeman M, Vernick KD, Sauerwein RW, Preiser PR, Mercereau-Puijalon O, Buffet P, Alano P, Lavazec C.

Blood. 2012 Jun 14;119(24):e172-80. doi: 10.1182/blood-2012-03-414557. Epub 2012 Apr 18.

19.

EBV Latency II-derived peptides induce a specific CD4+ cytotoxic T-cell activity and not a CD4+ regulatory T-cell response.

Moralès O, Depil S, Mrizak D, Martin N, Ndour PA, Dufosse F, Miroux C, Coll J, de Launoit Y, Auriault C, Pancre V, Delhem N.

J Immunother. 2012 Apr;35(3):254-66. doi: 10.1097/CJI.0b013e31824d72c5.

PMID:
22421943
20.

Inhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cells.

Ndour PA, Brocqueville G, Ouk TS, Goormachtigh G, Morales O, Mougel A, Bertout J, Melnyk O, Fafeur V, Feuillard J, Coll J, Adriaenssens E.

J Virol. 2012 Apr;86(7):3934-43. doi: 10.1128/JVI.05747-11. Epub 2012 Jan 18.

21.

Inhibition of tumor necrosis factor-induced phenotypes by short intracellular versions of latent membrane protein-1.

Ndour PA, Ouk TS, Brocqueville G, Mougel A, Vanhecke E, Feuillard J, Coll J, Adriaenssens E.

Cell Signal. 2010 Feb;22(2):303-13. doi: 10.1016/j.cellsig.2009.09.037. Epub 2009 Sep 29.

PMID:
19796681

Supplemental Content

Loading ...
Support Center